Aurinia Pharmaceuticals Inc. Increase (Decrease) in Other Noncurrent Assets
Aurinia Pharmaceuticals Inc. (AUPH) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- Aurinia Pharmaceuticals Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $0.00.
- Aurinia Pharmaceuticals Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $0.00.
- Aurinia Pharmaceuticals Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-06-30 was -$730.00K, a 2617.24% decline year-over-year.
- Aurinia Pharmaceuticals Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-03-31 was $0.00.
- Aurinia Pharmaceuticals Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was -$730.00K.
- Aurinia Pharmaceuticals Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was -$31.00K, a 293.75% decline from fiscal 2023.
- Aurinia Pharmaceuticals Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was $16.00K, a 95.59% decline from fiscal 2022.
- Aurinia Pharmaceuticals Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was $363.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month | Increase (Decrease) in Other Noncurrent Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | -$730.00K derived: sum of 3 quarters · filed 2026-08-06 | -$730.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$730.00K derived: sum of 2 quarters · filed 2026-08-06 | -$730.00K 10-Q · filed 2025-11-04 | -$773.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$730.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$730.00K 10-Q · filed 2026-08-06 | -$773.00K derived: sum of 3 quarters · filed 2026-08-06 | -$773.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-12 | -$43.00K derived: sum of 2 quarters · filed 2026-02-26 | -$43.00K derived: sum of 3 quarters · filed 2026-02-26 | -$14.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-12-31 | -$43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$43.00K derived: sum of 2 quarters · filed 2026-02-26 | -$14.00K derived: sum of 3 quarters · filed 2026-02-26 | -$31.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $29.00K derived: sum of 2 quarters · filed 2025-11-04 | $12.00K 10-Q · filed 2025-11-04 | $12.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $12.00K 10-Q · filed 2025-07-31 | $12.00K derived: sum of 3 quarters · filed 2026-02-26 | $12.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$17.00K 10-Q · filed 2025-05-12 | -$17.00K derived: sum of 2 quarters · filed 2026-02-26 | -$17.00K derived: sum of 3 quarters · filed 2026-02-26 | -$18.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | -$1.00K derived: sum of 3 quarters · filed 2026-02-26 | $16.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.00K derived: sum of 2 quarters · filed 2024-11-07 | $16.00K 10-Q · filed 2024-11-07 | -$451.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $16.00K 10-Q · filed 2024-08-01 | -$451.00K derived: sum of 3 quarters · filed 2025-02-27 | -$138.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $17.00K 10-Q · filed 2024-05-02 | -$450.00K derived: sum of 2 quarters · filed 2025-02-27 | -$137.00K derived: sum of 3 quarters · filed 2025-02-27 | $380.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | -$467.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$154.00K derived: sum of 2 quarters · filed 2025-02-27 | $363.00K derived: sum of 3 quarters · filed 2025-02-27 | $363.00K 10-K · filed 2025-02-27 | $839.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $313.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $830.00K derived: sum of 2 quarters · filed 2023-11-02 | $830.00K 10-Q · filed 2023-11-02 | $724.00K derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-06-30 | $517.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $517.00K 10-Q · filed 2023-08-03 | $411.00K derived: sum of 3 quarters · filed 2024-02-15 | $393.00K derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | -$106.00K derived: sum of 2 quarters · filed 2024-02-15 | -$124.00K derived: sum of 3 quarters · filed 2024-02-15 | -$124.00K derived: sum of 4 quarters · filed 2024-02-15 | |
| 2021-12-31 | -$106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$124.00K derived: sum of 2 quarters · filed 2024-02-15 | -$124.00K derived: sum of 3 quarters · filed 2024-02-15 | -$353.00K 10-K · filed 2024-02-15 | -$247.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | -$18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$18.00K derived: sum of 2 quarters · filed 2022-11-03 | -$247.00K 10-Q · filed 2022-11-03 | -$247.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$229.00K 10-Q · filed 2022-08-04 | -$229.00K derived: sum of 3 quarters · filed 2023-02-28 | -$229.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | -$229.00K 10-Q · filed 2022-05-10 | -$229.00K derived: sum of 2 quarters · filed 2023-02-28 | -$229.00K derived: sum of 3 quarters · filed 2023-02-28 | -$229.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $0.00 derived: sum of 3 quarters · filed 2023-02-28 | $0.00 10-K · filed 2023-02-28 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $0.00 derived: sum of 2 quarters · filed 2021-11-03 | $0.00 10-Q · filed 2021-11-03 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | ||||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B |